Restricted accessResearch articleFirst published online 2016-4
Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings,authenticity,and autobiographical disclosure in healthy volunteers in a controlled setting
The drug 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”, “molly”) is a widely used illicit drug and experimental adjunct to psychotherapy. MDMA has unusual, poorly understood socioemotional effects, including feelings of interpersonal closeness and sociability. To better understand these effects, we conducted a small (n=12) within-subjects double-blind placebo controlled study of the effects of 1.5 mg/kg oral MDMA on social emotions and autobiographical disclosure in a controlled setting. MDMA displayed both sedative- and stimulant-like effects, including increased self-report anxiety. At the same time, MDMA positively altered evaluation of the self (i.e. increasing feelings of authenticity) while decreasing concerns about negative evaluation by others (i.e. decreasing social anxiety). Consistent with these feelings, MDMA increased how comfortable participants felt describing emotional memories. Overall, MDMA produced a prosocial syndrome that seemed to facilitate emotional disclosure and that appears consistent with the suggestion that it represents a novel pharmacological class.
AdamsonSMetznerR (1988) The nature of the MDMA experience and its role in healing, psychotherapy and spiritual practice. ReVision10: 59–72.
2.
BaggottMJKirkpatrickMGBediG. (2015) Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol29: 669–677.
3.
BediGCecchiGASlezakDF. (2014) A window into the intoxicated mind? speech as an index of psychoactive drug effects. Neuropsychopharmacology39: 2340–2348.
4.
BediGde WitH (2011) Individual differences in acute responses to MDMA in humans: Effects of sex and past ecstasy use. Open Addict J4: 6–7.
5.
BediGHymanDde WitH (2010) Is ecstasy an “empathogen”? Effects of ±3, 4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry68: 1134–1140.
6.
BediGPhanKLAngstadtM. (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl)207: 73–83.
7.
BousoJCDoblinRFarréM. (2008) MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. J Psychoactive Drugs40: 225–236.
8.
BravoGL (2001) What does MDMA feel like? In: HollandJ (ed) Ecstasy: The Complete Guide. A Comprehensive Look at the Risks and Benefits of MDMA. Rochester, US: Park Street Press, pp. 21–28.
9.
CamiJFarreMMasM. (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (“ecstasy”): Psychomotor performance and subjective effects. J Clin Psychopharmacol20: 455–466.
10.
Carhart-HarrisRWallMErritzoeD. (2014) The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories. Int J Neuropsychopharmacol17: 527–540.
11.
CarletonRNMcCrearyDRNortonPJ. (2006) Brief fear of negative evaluation scale—revised. Depress Anxiety23: 297–303.
12.
GoldmanBMKernisMH (2002) The role of authenticity in healthy psychological functioning and subjective well-being. Ann Am Psychother Assoc5: 18–20.
13.
GreerGTolbertR (1986) Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs18: 319–327.
14.
GreerGRTolbertR (1990) The therapeutic use of MDMA. In: PeroutkaSJ (ed) Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Norwell, Massachusetts: Kluwer Academic Publishers, 21–35.
15.
HarrisDSBaggottMMendelsonJH. (2002) Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl)162: 396–405.
16.
HaslerFStuderusELindnerK. (2009) Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. J Psychopharmacol23: 923–935.
17.
HollisterLE (1968) Chemical Psychoses: LSD and Related Drugs, Springfield, Illinois: Charles C. Thomas.
18.
HorowitzMWilnerNAlvarezW (1979) Impact of Event Scale: A measure of subjective stress. Psychosom Med41: 209–218.
19.
HysekCMDomesGLiechtiME (2012) MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions. Psychopharmacology (Berl)222: 293–302.
KellyBCParsonsJTWellsBE (2006) Prevalence and predictors of club drug use among club-going young adults in New York city. J Urban Health83: 884–895.
22.
KernisMHGoldmanBM (2006) A multicomponent conceptualization of authenticity: Theory and research. Adv Exp Soc Psychol38: 283–357.
23.
KieslerDJ (1991) Interpersonal methods of assessment and diagnosis. In: SnyderCRForsythDR (eds) Handbook of Social and Clinical Psychology: The Health Perspective. Elmsford, NY: Pergamo, pp. 438–468.
24.
KirkpatrickMGBaggottMJMendelsonJE. (2014) MDMA effects consistent across laboratories. Psychopharmacology (Berl)231: 3899–3905.
LakeyCEKernisMHHeppnerWL. (2008) Individual differences in authenticity and mindfulness as predictors of verbal defensiveness. J Res Pers42: 230–238.
27.
LearyMR (1983) A brief version of the Fear of Negative Evaluation Scale. Pers Soc Psychol Bull9: 371–375.
28.
LentonAPSlabuLSedikidesC. (2013) I feel good, therefore I am real: Testing the causal influence of mood on state authenticity. Cogn Emot27: 1202–1224.
29.
LesterSJBaggottMWelmS. (2000) Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann Intern Med133: 969–973.
30.
LevineJRinkelMGreenblattM (1948) Psychological and physiological effects of intravenous pervitin. Am J Psychiatry105: 429–434.
31.
LiechtiMEVollenweiderFX (2000) Acute psychological and physiological effects of MDMA (“Ecstasy”) after haloperidol pretreatment in healthy humans. Eur Neuropsychopharmacol10: 289–295.
32.
LiechtiMEGammaAVollenweiderFX (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology (Berl)154: 161–168.
33.
LiechtiMESaurMRGammaA. (2000) Psychological and physiological effects of MDMA (“Ecstasy”) after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans. Neuropsychopharmacology23: 396–404.
34.
LingTDaviesL (1952) The use of methedrine in the diagnosis and treatment of the psychoneuroses. Am J Psychiatry109: 38–39.
35.
McCraeRRCostaPT (1989) The structure of interpersonal traits: Wiggins’s circumplex and the five-factor model. J Pers Soc Psychol56: 586–595.
36.
MaltbyJWoodAMDayL. (2012) The position of authenticity within extant models of personality. Pers Individ Dif52: 269–273.
37.
MaslowA (1968) Toward a Psychology of Being, New York: Van Nostrund.
38.
MithoeferMCWagnerMTMithoeferAT. (2013) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study. J Psychopharmacol27: 28–39.
39.
MorleyKCMcGregorIS (2000) (±)-3, 4-Methylenedioxymethamphetamine (MDMA,‘Ecstasy’) increases social interaction in rats. Eur J Pharmacol408: 41–49.
40.
NicholsDE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens. J Psychoactive Drugs18: 305–313.
41.
OehenPTraberRWidmerV. (2013) A randomized, controlled pilot study of MDMA (+/- 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol27: 40–52.
42.
PennebakerJWKingLA (1999) Linguistic styles: Language use as an individual difference. J Pers Soc Psychol77: 1296.
43.
ReissS (1991) Expectancy model of fear, anxiety, and panic. Clin Psychol Rev11: 141–153.
44.
RodgersJBuchananTPearsonC. (2006) Differential experiences of the psychobiological sequelae of ecstasy use: Quantitative and qualitative data from an internet study. J Psychopharmacol20: 437–446.
45.
RogersC (1961) On Becoming a Person: A Therapist’s View of Psychotherapy. Boston, MA: Houghton Mifflin Harcourt.
46.
SheldonKMRyanRMRawsthorneLJ. (1997) Trait self and true self: Cross-role variation in the Big-Five personality traits and its relations with psychological authenticity and subjective well-being. J Pers Soc Psychol73: 1380–1393.
47.
StuderusEKometerMHaslerF. (2011) Acute, subacute and long-term subjective effects of psilocybin in healthy humans: A pooled analysis of experimental studies. J Psychopharmacol25: 1434–1452.
48.
SumnallHRColeJCJeromeL (2006) The varieties of ecstatic experience: An exploration of the subjective experiences of ecstasy. J Psychopharmacol20: 670–682.
49.
TancerMEJohansonCE (2001) The subjective effects of MDMA and mCPP in moderate MDMA users. Drug Alcohol Depend65: 97–101.
50.
TausczikYRPennebakerJW (2010) The psychological meaning of words: LIWC and computerized text analysis methods. J Lang Soc Psychol29: 24–54.
51.
TaylorS (1993) The structure of fundamental fears. J Behav Ther Exp Psychiatry24: 289–299.
52.
TaylorSE (2006) Tend and befriend biobehavioral bases of affiliation under stress. Curr Dir Psychol Sci15: 273–277.
53.
TaylorSEKleinLCLewisBP. (2000) Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight. Psychol Rev107: 411–429.
54.
ThompsonMCallaghanPHuntG. (2007) A role for oxytocin and 5-HT 1A receptors in the prosocial effects of 3, 4 methylenedioxymethamphetamine (“ecstasy”). Neuroscience146: 509–514.
55.
TrapnellPDWigginsJS (1990) Extension of the Interpersonal Adjective Scales to include the big five dimensions of personality. J Pers Soc Psychol59: 781–790.
56.
VollenweiderFXGammaALiechtiM. (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology19: 241–251.
57.
WardleMCde WitH (2014) MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology (Berl)231: 4219–4229.
58.
WardleMCKirkpatrickMGde WitH (2014) ‘Ecstasy’ as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci 9: 1076–1081.
59.
WatsonDClarkLATellegenA (1988) Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol54: 1063–1070.
60.
WhiteN (2011) An examination of dispositional authenticity. Doctoral dissertation, Tempe, AZ: Arizona State University.
61.
WigginsJSBroughtonR (1991) A geometric taxonomy of personality scales. Eur J Pers5: 343–365.
62.
WigginsJSTrapnellPPhillipsN (1988) Psychometric and geometric characteristics of the Revised Interpersonal Adjective Scales (IAS-R). Multivariate Behav Res23: 517–530.
63.
WolfsonPE (1986) Meetings at the edge with Adam: A man for all seasons?J Psychoactive Drugs18: 329–333.
64.
WoodAMLinleyPAMaltbyJ. (2008) The authentic personality: A theoretical and empirical conceptualization and the development of the Authenticity Scale. J Couns Psychol55: 385–399.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
